INMB/ 05/14/2026 · 12:32 PM FDA Fast-Tracks INmune Bio’s XPro for Early Alzheimer’s Disease FDA gave Fast Track to INmune Bio’s XPro for early Alzheimer’s, speeding trials of a drug targeting brain inflammation.
